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ABSTRACT 
 
 Multiple Reaction Monitoring (MRM) is a powerful tandem mass spectrometry 
(MS/MS) tool frequently implemented in proteomic studies to provide targeted analysis 
of proteins and peptides.  The selectivity that MRM delivers is so strong that it provides 
the quadrupole mass spectrometers (QQQ), on which it is commonly employed, with 
pertinence to proteomic studies that they would otherwise lack for their relatively low 
resolution.  Additionally, this increased level of selectivity is sufficient to supplant 
complicated fractionation techniques, additional dimensions of chromatography, and 24 
hour long MS/MS experiments in simplistic biological samples.  But there is a deficiency 
of evidence to determine the applicability of MRM to complex samples such as those 
containing the entire proteome of single cellular organisms.  These samples are often 
employed to profile entire metabolic pathways at a cellular level using the complete set 
of proteins involved in the pathway’s characteristic enzyme driven reactions.  This 
sweeping view of gene expression is vital to understand cellular response, and profiling 
these expressions would benefit greatly from the introduction of MRM as a viable 
approach for characterizing metabolic networks.  This thesis takes two significant steps 
towards this viability by first demonstrating MRM reproducibility in complex samples, 
and characterizing degrees to which certain design related factors influence the quality 
of these MRM.  The next step applies knowledge gained by the first to exhibit the MRM 
profiling of a vital metabolic pathway from a complex sample.  This step also 
demonstrates the self-sufficient utility an ab initio method, based on proteins and 
peptides predicted from the genome sequence, for designing MRM.  Combining the ab 
initio design approach with the MRM of complex samples represents substantially 
shorter experimental preparations for profiling metabolic networks, and renders the 
characterization of gene expression on a cellular level as a more widely accessible 
study within proteomics. 
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Chapter 1:  Introduction to Targeted Proteome Characterizations 
 
1.1 Advent of Systems Biology 
As a relatively new and emerging paradigm in bioscience, Systems Biology is a 
remarkably large and interdisciplinary field that combines computational modeling, high-
throughput analytical methods, and state of the art data analysis in the holistic study of 
cellular metabolic pathways [1-4].  Rather than concentrating on isolated components, 
this integrated approach studies concerted biological activities as a unified network, 
which provides context for their interwoven causal nexus, and characterization of their 
mechanisms and purposes at the cellular level [5].  This new characterization insight 
provides a better understanding of cellular responses to environment, disease, and 
intercellular communications by offering a more direct connection between gene 
expressions within a cell and the stimuli that provoked them [3]. 
Molecular biology defines these gene expressions by the molecules and reactions 
they comprise.  A cell’s genes are contained in strands of deoxyribonucleic acid (DNA), 
and a gene expression begins when a cell transcribes a portion of its DNA to ribonucleic 
acid (RNA).  Then genetic information is translated from RNA into functional 
macromolecules known as proteins.  Some of these proteins are enzymatic which 
means that they catalyze reactions in life-sustaining metabolic pathways, such as 
glucose digestion and DNA synthesis[5, 6]; the latter example typifies the reticulate 
causal nexus mentioned earlier.  Each protein catalyzes a specific reaction, each viable 
combination of reactions maps out a specific pathway, and each pathway is activated by 
expressing the genes for the proteins that drive its reactions.  Due to their central role in 
this process, proteins provide a link between pathways and genes, and consequently 
they are a medium for monitoring gene expression[5].  This means that proteins can 
reveal detailed information about a cell’s structure and metabolic activity; which for 
bacteria, a single-cell life form, this means they also provide a comprehensive molecular 
profile of the entire organism. 
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1.2 Proteomics 
One component of the systems biology approach to molecular biology is proteomics, 
which is defined as profiling and characterizing entire metabolic pathways by identifying 
complete sets of proteins.   Such large scale profiling requires using a protein’s intrinsic 
properties to not only uniquely identify and accurately quantify it, but also to separate it 
from other proteins to assist these measurements.  Applying this practice to multiple 
proteins with multiple properties, while providing meaningful qualitative and quantitative 
data in one experiment, requires high throughput analytical techniques and instruments 
possessing both a wide dynamic range and an elevated level of identification.   
A staple analytical technique in proteomics is mass spectrometry (MS), which 
encompasses a multitude of strategies applied across a variety of instrumental 
configurations.  Like high performance liquid chromatography (HPLC) and two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE), MS is a high throughput 
technique that can analyze thousands of proteins in one experiment; however, it 
provides significant increase in identity specificity over HPLC and 2D-PAGE.  Rather 
than using a protein’s affinity to stationary phase (an external interaction), MS identifies 
proteins by their mass to charge ratio (m/z, an intrinsic chemical property). As an 
additional performance capability, HPLC can be coupled indirectly or directly to MS 
(offline or online LC-MS) to enhance both separation and subsequent MS identification, 
and can be augmented by adding a second chromatographic dimension before MS that 
operates on a different intrinsic property (2D-LC). 
Further specificity in LC-MS identity is achieved through a very common strategy 
known as bottom-up proteomics.  This strategy begins by digesting the proteins into 
peptides for MS analysis, then adding a second MS step that fragments (MS/MS).  The 
fragments identify the peptides and the peptides identify the protein, which minimizes 
ambiguity at the protein and peptide level.  Fragment based identifications are facilitated 
by a systematic nomenclature that identifies their portion of the peptide sequence.  
Each peptide has an amino-terminus and a carboxyl-terminus (N- and C- terminus 
respectively), and when a peptide ion breaks, the charge remains on either the N- or C- 
terminus leading to the detection of attached fragment.  N-terminus ions are labeled a-, 
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b-, or c- type ions, while C-terminus are labeled x-, y-, and z- type ions, as seen in 
Figure 1.1.  The three possible labels arise from three possible peptide bonds that could 
break to form a fragment, and ions of one terminus are complementary to ions of the 
other.  Specifically, a- and x- type ions are complementary and originate from breaking 
the alpha carbon to carbonyl carbon bond, b- and y- ions are complementary and 
originate from breaking the carbonyl carbon to amide nitrogen bond, and c- and z- type 
ions are complementary and originate from breaking the alpha carbon to amide 
nitrogen.  Since these bonds can occur multiple times in a peptide, with multiple 
possibilities of each ion type, the bonds are numbered in sequence from both termini, 
with each ion type numbered in turn.  For example a peptide with three carbonyl-amide 
bonds, such as the one in Figure 1.1, will have three b-type and three y-type ions as 
seen in Figure 1.2, with the complementary ions being b-1 and y-3, b-2 and y-2, and b-3 
and y-1. 
 As one of the preferred analytical methods in proteomics, bottom-up 2D-LC-MS/MS 
offers a very high level of specificity, yet such experiments can still run as long as 24 
hours to accommodate the complexity of proteomic samples.  Although individual run 
times can be shortened by performing the first LC separation offline (fractionation), this 
strategy requires multiple runs and time consuming sample preparation. 
The various methods of proteomic MS can be divided into two categories: global and 
targeted, and each one presents advantages and challenges.  The global approach is 
and enables the single experiment profiling of multiple metabolic pathways under that 
sample’s conditions; this can also retroactively apply to proteins and pathways not yet 
linked.  However, with so many peptides and fragments to separate and scan from a 
continuous flow, some less abundant proteins will not be identified, which in turn means 
that some metabolic pathways may be expressed but lack enough data for a profile.   
The targeted approach looks for specific proteins in order to profile select metabolic 
pathways.  Targeted experiments require prior knowledge of protein-pathway links, and 
they ignore a large majority of proteins, hence the data from these experiments will not 
be applicable outside of the chosen pathways.  However, this focused scanning allows 
targeted experiments to measure proteins that would otherwise go undetected, and to  
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Figure 1.1 Diagram of peptide fragment labeling, courtesy of Matrix Science [7] 
 
 
 
Figure 1.2 B- and y-type ions to show charge placement, courtesy of Matrix 
Science [7] 
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profile pathways of interest that would otherwise lack sufficient data.  Additionally, this 
narrow view can facilitate the measurement of absolute protein concentrations, and thus 
better measure the scope of a gene’s expression. 
 
1.3 Targeted Proteomics 
Although targeted detection of proteins and targeted MS have both existed for 
several decades, targeted MS is a relatively new addition in proteomics.  Older targeted 
techniques, such as affinity chromatography and western blotting, exploit the selective 
binding between enzymes and substrates, or antigens and antibodies to achieve highly 
specific protein isolation and detection[8].  However, these techniques rely on the 
careful execution of complex and time consuming sample preparations and processes. 
Targeted MS analysis is based on an MS/MS technique known as selected reaction 
monitoring (SRM), and similar to a previously discussed concept, it utilizes mass 
instead of interaction to achieve specific isolation and detection.  Within MS/MS the 
select profiling of SRM differentiates it from global MS/MS which is designed to identify 
thousands of proteins and peptides in one experiment.  Global analysis scans all 
peptide charge-state (precursor) m/zs and all fragment m/zs, while SRM scans for one 
specific precursor m/z, with one specific fragment m/z.  Each pairing of specific m/zs, 
one precursor with one fragment, is called a transition, and when multiple transitions are 
targeted, the experiment is called a multiple reaction monitoring (MRM).  Each protein 
contains a number of unique amino acid sequences found among some of the peptides 
it comprises, and MRM can identify such a peptide by detecting its unique transitions.  
These unique peptide identities provide protein identities as specific as those obtained 
by traditional targeted techniques. 
Being both a targeted approach and an MS method, MRM offers a few unique 
advantages.  First, compared to other MS approaches, it requires less scans per 
experiment, which affords it more time per scan while reducing overall time for the 
experiment. Next, MRM’s selective detection allows it to identify low abundance proteins 
with less fractionation than global MS, and MRM can even be performed with only one 
dimension of chromatography (1D-LC).  Also, because isolation and detection take 
6 
 
place inside the instrument, MRM requires far less sample preparation than other non-
MS targeted approaches.  Finally, MRM can be performed on relatively low cost, and 
readily available, instruments without requiring expensive antigen tags, making it one of 
the least expensive options of both targeted and MS methods. 
Despite its youth, MRM is a widely accepted method, and as it is backed by 
substantial precedent, MRM related research continues to grow for both proteomics in 
general, as well as for its own development [9].  The instrumental backbone for MRM 
research and application has historically been the triple quadrupole mass analyzer 
(QQQ), but utilization of the recently developed quadrupole-Orbitrap (Q-Exactive) is 
steadily increasing as this instrument offers advanced resolution [10, 11].  Other 
recently proposed advancements include methods for single-transition-based MRM 
identities and standard protocols to evaluate MRM system performance [11, 12]. 
Currently, employment of MRM includes profiling protein networks, quantifying post-
translational modifications, and disease biomarker verification[9].  Recent specific 
examples of MRM applications include research by Gall et al[6] in developing a sub-5-
minute method for measuring blood plasma concentrations of rufinamide in low volume 
samples, and another study by Li et al [13] developed a method for quantitative 
measurement of arenobufagin in rat plasma, which was also a 5 min method.  
Representing samples outside of plasma, Vierikova et al [14] developed an MRM 
method for determining the natamycin content of cheese in a 14 min measurement. 
The success of proteomic MRM is due in large part to advanced bioinformatics tools, 
such as the popular software application Skyline [15].  The applicability of this software 
is evident throughout every step of MRM development; specifically, it can be used to 
design, evaluate, and modify a method, as well analyze final MRM data.  Skyline’s 
versatility will be discussed further in chapter two. 
 
1.4 Thesis Objectives 
Thus far, MRM has been applied to relatively simplistic sample sets, such as blood, 
serum, urine, or even cheese.  Yet it poses the potential to interrogate large 
unfractionated samples containing whole proteomes of multiple organisms.  Placing 
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greater emphasis on tuning the MRM methods and instruments allows the sample to 
remain complex; this reduces the time, money, and mistakes risked in both planning 
and executing individual sample preparations for each study. 
However, designing and tuning a specialized MRM for each study is a daunting task 
that presents its own potential errors and fruitless endeavors.  Meaningful experimental 
design requires guidelines that point out subtle yet fatal flaws, and help maintain a focus 
on pertinent issues.  The work presented in this thesis was devised to offer such 
guidance by first identifying factors that have a potentially significant impact on MRM 
design, then conducting comparative MRM’s that focus on those factors, and finally 
evaluating both the quality of the resulting MRM data and the effects of each factor on 
that quality. 
The research conducted in pursuit of this goal was split into two projects, with two of 
the following chapters of this thesis dedicated to discussing how each was designed, 
executed, and evaluated.  The first project, as presented in chapter three, fields the 
fundamental question: “Can MRM of peptides in an unfractionated sample, containing 
whole proteomes of multiple organisms, be reproducibly accomplished?”  Additionally, 
this project identifies and investigates chromatographic congestion and peptide 
abundance for their potential influence on MRM quality.  Chapter four encompasses the 
expansion project, which responds to the challenge: “Can such an ambitious MRM be 
employed to profile an entire metabolic pathway?”  In the course of facing this gauntlet, 
this project also provides a comparison of two competing methods for MRM design, 
empirical and ab initio.  Each of these projects are complimentary to the other; the first 
is a proof of concept study that provides the basis for the second, which itself is an 
applicable demonstration that brings relevance to the first.  Together, these symbiotic 
projects present a defendable method for designing an MRM to profile metabolic 
pathways in a complex sample of complete proteomes. 
With the success of these projects in meeting both their individual goals and the 
overarching objective, this thesis will deliver three contributions to the advancement of 
proteomic MRM within systems biology.  First, it will demonstrate that MRM’s strength in 
eliminating a significant amount of sample preparation can be further applied to samples 
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of complete proteomes.  Second, this thesis will explore the limits of how complex an 
MRM sample can be while still returning meaningful data.  Finally, the work presented in 
this study will demonstrate the ability of MRM to characterize a specific metabolic 
pathway in a complex sample, containing the complete proteomes of several 
organisms, without fractionation, in 60 min. 
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Chapter 2:  Experimental Approach for Targeted Proteomics 
 
2.1 Overall Experimental Design 
Fulfilling the goals of this thesis relied on carefully designing the experiments for 
each project, based on a significant understanding of biological samples, established 
methods, and instrumental mechanics.  This chapter will outline and define these 
concepts through a detailed discussion of the experimental designs.  First, the contents 
of the selected sample will be described to define its merit in testing MRM designs.  This 
will be followed by a discussion on relevant sample preparation, sample loading, and LC 
methods.  Next, a brief explanation of the ion source will connect LC to MS/MS, and 
explain the origin of multiple peptide precursors.  The two sections that follow will cover 
the two types of mass analyzers employed by this thesis, and will describe how both 
instruments play a role in each project.  These sections will also serve as a comparison 
for how each mass analyzer achieves MS/MS.  Finally, this chapter will focus on the 
software employed in collecting, calculating, and evaluating data.  This portion will also 
look closer at the specific contribution provided by Skyline.  
 
2.2 Microbial Sample Selection 
A model synthetic microbial consortium consisting of the microbes Escherichia coli, 
Rhodopseudomonas palustris, Ignicoccus hospitalis, and Nanoarchaeum equitans (E. 
coli, R. pal, I. hos, N. equi) was prepared to evaluate the design and execution of each 
MRM in a moderately complex but highly controlled biological system.  For this four 
isolate system (4-iso) there are approximately 11,000 possible proteins, based on 
genome evaluations.  Assuming that each microbe could express about one-half of its 
genome products under one growth condition would suggest a possible pool of about 
5,500 protein products.  This would yield over 80,000 possible tryptic peptides in the 
sample.   
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2.3 Sample Preparation and Separations 
The samples were prepared and loaded according to in-house techniques and then 
separated by an in-house LC method that was modified for a 60 min 1D-LC run; the 
polar and nonpolar solvents used therein were also prepared in house[16].  The polar 
solvent (solvent A) is 5% acetonitrile (ACN), 95% HPLC-grade water, and 0.1% formic 
acid; the nonpolar solvent (solvent B) is 70% ACN, 30% HPLC-grade water, and 0.1% 
formic acid. 
The microbial samples were pulse-sonicated for 2 min and boiled for 5 min in a 
sodium dodecyl sulfate (SDS) solution, resulting in cell lysis, and yielding proteins which 
were immediately precipitated with trichloroacetic acid (TCA).  After being washed and 
re-solubilized, the proteins were then digested with sequencing-grade trypsin for 
approximately 12 hours, which cleaved the proteins into their constituent peptides at 
lysine and arginine residues.  For each MS/MS run, 5 to 10 μg of peptides were bomb-
loaded onto a fused silica back column packed to approximately 5 cm with Kinetix C18 
reverse-phase (RP) resin, and washed offline with solvent A.  Next, the back column 
was placed in line behind a nanospray emitter that was approximately 10 cm long and 
packed full length with C18 RP resin.  The peptides were then separated by 1D-LC with 
a 60 min gradient from 2% solvent B to 90% solvent B, at a flow rate of 300 nl per 
minute.   
 
2.4 Electrospray Ionization/Nano-Electrospray 
Nano-flow electrospray ionization (Nanospray) was employed for interfacing the LC to 
the MS/MS.   Figure 2.1 shows this atmospheric pressure interface, and Figure 2.2 
illustrates the basic operation of nanospray in which the peptide laden solvent is passed 
through a charged needle to form charged droplets.  These charged droplets accelerate 
through a potential gradient to the inlet port of the spectrometer; meanwhile the solvent 
evaporates until the droplets break into charged peptide ions.  Solvents A and B both 
contain ACN, which is a volatile organic that aids in solvent evaporation; they also both 
contain formic acid to increase droplet conductivity.  By utilizing nanoliter flow rates, 
nanospray decreases solvent volume and increases ion formation. For both projects,  
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Figure 2.1 Nanospray Interface for LC-MS/MS.  The pulled nanospray tip of the 
fused silica tubing is shown on the right; this connects the flow from the LC 
column to the ESI source of the MS and is open to atmosphere.  This nanospray 
tip is localized a few mm. away from the heated metal capillary (shown on the left) 
of the ESI source of the MS. 
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Figure 2.2 Basic illustration of nano-flow electrospray ionization, courtesy of 
Dionex[17] 
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nanospray flowed at 300 nL per minute, as set by the LC pump.  A voltage between 
2300 and 2700 volts was used to establish the electrospray ionization conditions. 
The amount of charge a peptide ion receives can vary, which gives rise to multiple 
precursors ions for one peptide.  Although they have a minimal difference in mass, 
these precursors will differ greatly in m/z according to their charge.  Typically, 
nanospray ions range in charge from +1 to +4, but +2 ions are the most commonly 
detected by MS/MS.  This is because +1 ions often lack enough charge repulsion to 
fragment, while the +3 ions and up have too much charge repulsion to be easily 
formed[18]. 
 
2.5 Global Proteome Characterization using 1D-LC-MS/MS 
After peptide elution from 1D-LC and ionization by nanospray, the ions enter the MS 
and are targeted for tandem mass spectrometry (MS/MS).  Within the confines of this 
study, all MS/MS analysis, both global and targeted, was solely performed in the cells of 
quadrupole mass analyzers.  A quadrupole cell is a square array of four hyperbolic 
metal rods to which voltages are applied for the manipulation of ion trajectories.  Any 
two rods that are opposite each other in the array are connected electrically, and as this 
occurs twice in a quadrupole, it is better to view the array as being two pairs of rods 
rather than four individual rods. 
All global 1D-LC-MS/MS measurements were made using a Thermo-Fisher LTQ-Velos 
Pro linear trap quadrupole mass spectrometer (LTQ).  An LTQ is one continuous cell, 
split into three array sections, designed to trap ions inside and then analyze them.  A 
diagram of an LTQ is shown in Figure 2.3.  An ac voltage at a constant radio frequency, 
known henceforth as RF, is applied to the rods to guide ions along the axis of the cell.  
Meanwhile three separate dc voltages are applied to the three sections to create 
potential wells that confine axial ion movement to be within the cell, and effectively trap 
the ions.  Before each analysis, the trap opens for a discrete duration to accumulate 
ions, and a helium damping gas in the cell helps slow incoming ions to facilitate trapping 
by the voltages.  During and after analysis, ions are ejected through slots in the center 
section, for which it is termed the exit rods. 
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Figure 2.3 Basic diagram of linear ion trap quadrupole rod assembly, courtesy of 
Thermo Fisher Scientific[19] 
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To perform MS/MS, the LTQ accumulates ions and then conducts MS1 isolation, 
precursor fragmentation, and MS2 scan out.  This MS/MS is termed tandem in time, as 
the three steps occur sequentially and in the same cell.  The latter quality is enabled by 
applying, to the exit rods, an additional ac voltage that can vary in frequency or even 
comprise several at once.  All ions in the trap oscillate at discrete frequencies as 
determined by both their m/zs and the RF amplitude; and when the ac’s frequency 
matches an ion’s, they resonate, and impart the ion with enough kinetic energy to cause 
its ejection from the trap or its collisions within.   
During MS1, the ac is multi-frequency and can resonate with ions of a handful of 
m/zs at once.  A ramp in the RF, from low to high amplitude, excites one handful after 
another into resonance to cause their ejection into waste.  But a discrete gap in the ac-
RF combination matches one specific m/z, which results in these precursor ions being 
isolated in the cell.  The ac frequency then changes to resonate with the precursors, but 
without an RF ramp, so they stay in the cell and collide with the helium damping gas.  
The collisions convert the ions kinetic energy into internal energy, causing them to 
dissociate into fragments in a process known as collision induced dissociation (CID); the 
resulting fragments have different m/zs and thus different frequencies.  Finally, MS2 
scan out occurs by setting the ac to one frequency, and ramping the RF to move 
fragment ions into resonance, one at a time, according to their m/z.  This results in the 
sequential ejection of fragment ions, but this time into the detector.  It is important to 
specify at this point that CID predominantly produces b- and y-type ions [7, 20], and for 
the remainder of this thesis, all fragments can be assumed to be one of only these two 
types. 
If just an MS1 scan is desired, as to detect any precursors present at a given time, 
the LTQ does not isolate or fragment, but only scans ions out as described above.  This 
is important, as the LTQ can use MS1’s to guide itself through global MS/MS, and 
consequently boost the efficiency therein.  Specifically, the LTQ runs an MS1 scan and 
picks the most intense precursors detected, then it runs consecutive MS2 scans on 
each pick, starting with the most intense; user input predetermines the number of picks 
per MS1 scan, and number of MS2 scans per pick.  This process is known as a data-
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dependent scan, and it is repeated over the entire duration of a global MS/MS 
experiment.  As the LTQ is picking the most intense precursors from an MS1, it 
temporarily ignores any precursors picked from prior MS1 scans, and this duration is 
also set by user input.  This process is termed dynamic exclusion, and its purpose is to 
provide MS2 scans on precursors that may be less intense, but are no less important.   
Global MS/MS experiments in this study were run with one MS1 scan followed by 
twenty MS2 scans, one each for twenty precursors, and a dynamic exclusion time of 1 
minute.  The resolution of a scan is determined by the mass of a detected ion, divided 
by the difference in mass between two adjacent distinct ions.  In the case of peptides, 
with masses from 400 to 1700 Daltons, being able to separate a 0.5 Dalton difference 
requires a resolution of 800 to 3400.  Both MS1 and MS2 have a resolution of 1000, 
which can separate peptides with an approximately 0.5 to 1.5 Dalton difference in mass, 
depending on the mass of the peptides being separated. 
 
2.6 Operational Principles of the QQQ-MS System 
A Thermo TSQ Quantum triple quadrupole mass spectrometer (QQQ) was used for 
all the targeted 1D-LC-MS/MS measurements in this study.  A QQQ is three single-
array cells that are isolated and arranged in sequence, as seen in Figure 2.4.  There is 
no axial trapping, but rather a continuous ion stream travels from source to detector, 
through each cell along its axis.  Ion oscillation stability is controlled through variable RF 
and dc voltages, where RF are applied to all three cells, but dc are applied only to the 
first and third.  Again it is best to view the rods of each cell as two pairs, and the 
voltages applied to one pair of rods are of equal amplitude but opposite sign as those 
applied to the other pair, as seen in Figure 2.5.   An additional dc voltage is used as an 
offset and will be referenced only as “offset” to prevent confusion.  The offset is applied 
to all three cells, and with equal amplitude and sign for their two rod pairs.  It controls 
ion acceleration, and thus controls ion translational kinetic energy (TKE). 
MS/MS on a QQQ is termed tandem in space, because it is done by distributing the 
three steps, in sequence, among the QQQ’s three cells.  The first cell, designated Q1, 
operates as the MS1 mass analyzer and isolates precursor ions, according to their  
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Figure 2.4 Basic diagram of a triple quadrupole mass analyzer, courtesy of 
Thermo Fisher Scientific[21] 
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Figure 2.5 Diagram of electrical connection for the quadrupole rod assembly of 
the QQQ, courtesy of Thermo Fisher Scientific[21] 
  
19 
 
m/zs, by applying varying ratios of RF to dc.  A given ratio of voltages will cause 
precursor ions of a specific m/z to have controlled oscillations and travel through Q1 to 
the next cell.  Ions of any other m/z will oscillate out of control and either crash into the 
rods or be ejected from Q1.  As the RF and dc are varied, their ratio is changed, and 
ions of a new m/z are brought into stable oscillation, while ions of the previous m/z join 
the others in instability.   
Precursor ions, isolated in Q1, then enter the second cell, termed Q2, which 
functions as the collision cell.  There is no dc applied to Q2, but there is a variable RF 
that provides stable oscillations to ions over a wide m/z range.  Also, Q2 contains argon 
gas for the precursors to collide with and subsequently undergo CID; the energy for 
which is provided by an ion’s TKE as determined by the offset.  The ions follow a path, 
set by the voltages, through a curve in Q2 (Figure 2.4), while neutral molecules miss the 
turn and are ejected from the cell, thus this simple curve dramatically reduces noise in 
the spectrum.  The fragment ions generated in Q2 then pass into the third cell, Q3, 
which is the MS2 mass analyzer.  Q3 operates by the same mechanism as Q1, and 
isolates fragment ions one after another for passage to the detector. 
There are a couple of important differences between MS/ MS on a QQQ and that on 
an LTQ.  By using argon instead of helium as a collision gas, QQQ fragmentation is 
more extensive, and requires less kinetic energy, than that of LTQ.  Because argon is 
bigger and heavier than helium, a collision with argon converts more of the ion’s kinetic 
energy into internal energy than for a collision with helium.  The other difference is 
MS/MS scans are faster on the QQQ than on the LTQ.  Since the QQQ is tandem in 
space, there is no waiting for ions to accumulate before isolation begins, or waiting for 
one step to finish before starting the next.   Precursor isolation, CID, and fragment 
isolation are simultaneously performed in their respective cells.  However, the ion 
stream experiences them sequentially, and on the fly, as it passes from one cell to the 
next; and MS/MS takes only as long as ions going from source to detector.  That is to 
say, tandem in space scans occur in real time in as little as 0.001s; this renders the 
QQQ ideal for targeted MS/MS, which in turn affirms its value to proteomics despite 
have unit resolution. 
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2.7 Targeted Proteomics with Multiple Reaction Monitoring (MRM) 
The construction of a proteomic MRM method involves selecting several of a 
protein’s unique peptides, then selecting several unique transitions for each peptide.  
This collection is called a transition list, and is used by the QQQ’s operating software to 
guide the targeted detection of transitions.  The resulting spectra can then be used for 
the selective identification and measurement of peptides.  Naturally, as more transitions 
are detected with strong signals, confidence in the identity of the target peptide 
increases, and the possibility of an interference peptide being identified decreases.   An 
interference peptide is a regularly occurring peptide with the same precursor m/z as the 
target, and is often called an isobaric peptide.  Also, it can produce some of the same 
fragments, or fragment m/zs, as the target, which means that some transitions are 
shared among the target and interference peptides.  It also means that as an 
interference peptide passes through the QQQ, it produces a signal for any shared 
transitions that are being monitored.   
Interference can be remedied through careful transition selection, as exemplified by 
selecting larger peptides, selecting larger fragments, selecting more fragments, and 
using early MRM’s as feedback for designing later ones.   Larger peptides, between ~10 
to ~25 amino acids long, make better selections for a couple of reasons.  First, these 
peptides most often exist as +2 ions, and although they can form ions of +3 or higher, 
few of them have to in order fit the QQQ’s mass range of 30 to 1500 Daltons.  Second, 
a large peptide can produce large fragments, and a large number of fragments.  Large 
fragments, such as b/y-6 to b/y-12 ions, have greater portions of their peptide’s 
sequence, which gives the fragments a less replicable m/z and makes them more 
characteristic of the target peptide.  And with a larger number of fragments, comes a 
lower chance that a significant number of them will be shared with any one isobaric 
peptide.   
All of the above translates into large peptides having more transitions that are more 
unique and more likely to occur. Additionally, targeting numerous transitions for each 
peptide in an MRM provides more evidence on which to determine authenticity.  Finally, 
the results of the MRM can be used to identify which transitions are shared, which are 
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unique, and how the unique compare in signal strength.  With this information, the 
transition list can be purged of shared transitions followed by the weakest, until 3 to 6 of 
the strongest and most confident transitions per peptide remain for further MRMs.  This 
dramatically improves confidence in peptide I.D. and subsequently protein I.D.  It is with 
this high level of confidence exhibited in proteomic MRM, that the QQQ deflates the 
effects of low resolution. 
As important as it is to have many peptides and transitions, there are limitations and 
performance tradeoffs.  One explicit limitation in the QQQ software’s operating 
parameters is that the transition list is limited to 320 transitions and cannot have 
duplicates.  Notable performance tradeoffs exist between list size and duty cycle, as 
well as scan time and sensitivity.  Duty cycle is a transition’s scan time as a percentage 
of the list’s scan time.  Only one transition can be scanned at a time, and the entire list 
must be scanned before starting again; so as the list increases, the scan time 
increases, and transition duty cycle decreases.  And although a transition can be 
scanned in 1ms, it comes at the expense of lost sensitivity; conversely, in order to 
increase sensitivity, scan time must increase as well.   Thus, even if scans take only 
tens of milliseconds, having a large list scanned with high sensitivity means those 
milliseconds add up; meanwhile, the peptides continuously flow off the column, each for 
a limited amount of time, and many for as little as 30 seconds.   With a list of 320 
transitions, each transition has a duty cycle 0.31% of the scan time, and at 20ms per 
scan, each will be scanned once every 6.4s.  If a peptide elutes for 30 seconds, a 
transition will only be scanned 4 or 5 times, which means at best 5 data points will be 
acquired to plot a transition’s entire profile.  But a list of 75 transitions provides each 
transition with a duty cycle of 1.3%, which translates to 20 data points.  Therefore, it is 
best to limit the number of peptides per protein, and transitions per peptide to the top 3 
to 6 each.  And when an experiment requires a large number of transitions, there will 
need to be a compromise between the amount scanned in one run, and the quality of 
each.  The targeted MS/MS experiments in this study were run with a scan time of 
20ms, with the offset voltage individually set for each transition as will be explained 
below.  The transition lists ranged in size from the mid 70’s to the 310’s depending on 
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the nature of the MRM experiment. 
 
2.8 Bioinformatics Methods for Data Analysis 
Proteomic MRM design requires prior knowledge on proteins, peptides, and 
transitions.  Specifically, transition list selection requires data on which peptides are 
unique to protein, and which precursor and fragment m/zs represent the most unique 
transitions; this data must also provide the suitability of each peptide, precursor, and 
fragment for MS/MS detection.  As will be extensively discussed in chapter 4, this data   
can be generated and evaluated through empirical measurements or theoretical 
calculations.  However, neither route is possible without precise sample information that 
includes organism identity, protein sequence, protease identity, peptide length, peptide 
sequence, number of missed peptide cleavages, fragmentation mechanism, and 
fragment ion type.  Reading, matching, calculating, and processing this information 
would be impossible without a work belt full of purpose built software tools. 
As mentioned above, this study presents two methods to gauge which peptides will 
be best detected in MRM.  The first will be called the empirical method, and employs 
measurements attained with traditional global MS, such as those made on the LTQ.  
The second method will be termed the ab initio method, and like its namesake, it relies 
solely on theoretically calculated probabilities.  An exhaustive comparison of these two 
methods is offered in chapter 4, but what follows is a comprehensive list of the 
programs and scripts used by each method, along with a brief description of their 
functionality. 
Empirically employed software extracts a variety of technical data on proteins and 
peptides from MS1 and MS2 measurements, which are generated by global MS and 
contained in a raw file.  After an MS experiment, the raw file and a sample-specific 
protein database, called a FASTA, are loaded into MyriMatch[22], which is also given 
the protease I.D., fragmentation mechanism, and number of missed cleavages to allow.  
MyriMatch then predicts peptides from the FASTA according to the given settings and 
reads the raw file for matches.  These matches are displayed in IDPicker[23] and 
provide identities for proteins and their peptides, along with showing the associated 
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peptide MS2 spectra.  Having a list of each protein’s peptides, and knowing how they 
fragment, is the first step in selecting peptides and transitions.  
Picking the best fragments for each transition can be done straightforwardly by 
looking at a peptide’s MS2 spectra.  But selecting the best peptides to start with takes 
further navigation, and offers several paths that focus on different qualifiers.  Two paths 
were followed in this study, one in chapter 3 and one in chapter 4, and each was laid 
out with different software.  The characterization study in chapter 3 required software 
that assisted in defining discrete time bins.  This same software was used to evaluate 
each peptide’s abundance for their guided selection.  Chapter 4 had no such time 
constraint, which allowed the use of software that provided a more comprehensive 
evaluation of peptide abundance. 
The first path used an in-house script called gitR_MS that reads IDPicker results and 
matches peptides to their MS1 scan number.  Then, MASIC[24] reads the raw file 
mentioned above to match MS1 scan numbers with their scan times and the ion current 
for each m/z in a given MS1scan, and it calculates the total ion current (TIC) for that 
scan.  The peptides are matched to their MS1 scan times and ion currents to 
simultaneously provide the time stamp and abundance.  Here, peptide abundance is 
defined by a peptide’s percent contribution to the TIC of the MS1 scan in which it was 
found. 
The second path is laid out by another in-house script named POSI, which uploads 
the IDPicker files and the FASTA to match peptides to their multiple MS2 scan 
intensities, a combination termed matched ion intensity (MII).  The MIIs for each peptide 
were summed and averaged across the number of MS2 scans for that peptide; peptide 
abundance in this path is defined by the log of the product of a peptide’s summed MII 
and averaged MII.  This means that abundance here considers both the quantity and 
quality of MS2 scans for a peptide. 
The software employed by the ab initio method provides probabilities and scores to 
assist in transition selection, and operates by internal calculations done on user 
provided input, according to user defined parameters.  Peptide selection was guided by 
PeptideSieve[25], which uploads a FASTA and is given the protease I.D., peptide 
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lengths to allow, number of missed cleavages to allow, and ionization method.  It 
generates a list of predicted peptide sequences, and assigns them detection 
probabilities based on their amino acid composition and physiochemical properties.  
After picking peptides, fragment selection begins with assistance from PepNovo[26].  
PepNovo is given a list of peptide sequences and charge states, and instructed on what 
fragmentation method, protease I.D., and post translational modifications (PTM) to 
consider.  It gives the top fragments for each peptide, the number of which is user 
defined, and provides each fragment’s score based on length and amino acid 
composition.  
It’s important to note here, that the outputs from programs and scripts mentioned 
above were loaded into excel for further extensive processing.  Data processing tasks 
performed in Microsoft Excel included, but were not limited to, searching, matching, 
filtering, sorting, grouping, summing, averaging, ranking, highlighting, and graphing. 
Although reams of informative input on MRM design came from several programs 
and scripts, the actual MRM design and evaluation was performed solely with 
Skyline[15].  Like some of the programs above, Skyline uses a FASTA and protease 
I.D., and with these it generates a hierarchical transition list.  The highest rank list is of 
the proteins to be searched for and characterized, and each protein can be expanded to 
display a list of its possible peptides.  Each peptide can then be expanded to show its 
possible precursor m/zs, and finally each precursor can be expanded into a list of its 
possible fragment ions.  This tiered approach can be seen in Figure 2.6.  In Skyline, any 
proteins, peptides, precursors, or fragments can be manually deleted from the list; doing 
so, as guided by the scores and probabilities mentioned above, can provide a short list 
of transitions with high probability and high duty cycle.  Additionally, it can predict each 
precursor’s optimum fragmentation energy and provide the corresponding offset 
voltage. Once finished, Skyline can export a transition list file, which contains for each 
transition:  the precursor m/z to monitor in MS1, the offset voltage for optimum 
fragmentation, and the fragment m/z to monitor MS2.  Finally this file is uploaded to the 
QQQ and guides it through an MRM experiment. 
The use of Skyline does not end at exporting a transition list; when the MRM is  
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Figure 2.6 Tiered display of proteins, peptides, precursors, and transitions as 
seen in Skyline[15] 
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done, the resulting raw file is uploaded into Skyline to evaluate the MRM design based 
on each transition’s performance.  Figure 2.7 demonstrates how the results are 
presented in Skyline; it displays an overlay of the chromatograms of all transitions for 
one peptide precursor at a time, and the intensities are shown relative to the highest 
available for a given zoom.  This overlay allows the user to quickly see which transitions 
produced the highest peaks, which transitions have the least noise, and where on the 
chromatogram transition peaks overlap.  The latter is the most important in 
authenticating that peaks originated from the desired peptide, and this will be discussed 
further in chapter 3.  Beyond displaying the chromatograms, Skyline also evaluates their 
signals at a selected peak and offers individual ranks for each transition present in a 
given selection, as shown on the left of Figure 2.7.  Utilizing the chromatograms and 
ranks, facilitates transition list improvement by showing which to keep and which to 
discard or replace depending on the number. 
Once the transition list is optimized, it can be used to run multiple technical 
replicates of an MRM experiment, the results of which will again be loaded into Skyline.  
The replicate chromatograms provide a ready visual for comparing retention times, peak 
intensities, and peak area ratios.  To facilitate this visual evaluation, Skyline can 
produce bar charts and scatter plots of the transitions peak areas and retention times as 
comparisons across peptides or across replicates.  It can also provide numerical data 
for exact comparisons of each peptide’s reproducibility by exporting a report on the 
MRM results.  Among a multitude of other metrics, a report can contain each transition’s 
retention time and peak area, and each peptide’s retention time as a function of its best 
transition, and peak area as a sum of its transitions.  The report automatically displays 
the data by replicate, but it can provide averages over all the replicates, along with 
ranges, standard deviations, and coefficients of variability.  By generating 
chromatograms, charts, and reports, Skyline offers a comprehensive view of the results, 
and provides a self-sufficient platform for evaluating MRM design. 
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Figure 2.7 MRM results with transition ranks as displayed in Skyline[15].  Upper 
left portion displays tiered approach, while different colored lines on the right 
indicate separate transitions. 
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2.9 Summary 
This chapter laid out the experimental design of each project to provide a context for 
the explanation of the materials and methods presented in this study.  Within this 
context was a description of the content of the 4-iso sample used for both projects, 
offered as an argument of how this sample would challenge the scope, and characterize 
the effects, of the complexity of a sample analyzed by MRM.  The techniques used for 
sample preparation and loading, as well as the LC method employed, were consistent 
throughout each project; and as they lack offline fractionation or secondary 
chromatography, they further emphasize the difficulty present in the analysis of this 
sample.  By explaining the operation of the spray source, it was shown how ionization 
generates multiple peptide precursors.  Operations of the both LTQ and QQQ were 
covered and comparisons were made as to how each approaches tandem MS.  These 
comparisons showed how LTQ data functioned for both defining congestion and 
empirically designing MRM, while the QQQ was the workhorse for all MRM experiments 
and provided data characterizing and evaluating MRM performance.   Finally, the 
software was laid out to show how data was processed to provide definitive 
measurements on MRM reproducibility in a complex sample. 
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Chapter 3:  Peptide Peaks Growing Up in a Tough Chromatographic 
Neighborhood:  Characterizing MRM Reproducibility and Robustness in Complex 
Microbial Samples 
 
3.1 Design of MRM Experiment 
MRM is typically performed using one dimensional chromatography, which can be 
problematic for very complex samples due to challenges from incomplete separations 
and ion suppression leading to diminished reproducibility.  The first project of this thesis 
was tailored to evaluating such reproducibility under these conditions so that a 
systematic method of selecting target peptides could be developed for MRM in complex 
samples with 60 minute 1D-LC.  This chapter chronicles the design and execution of 
this project and begins with discussions on identifying congestion and abundance as 
factors to be characterized for their influence on MRM quality, as well as the reason for 
limiting the number of target peptides.  Then, the mechanics of filtering the pool of 
peptides down to the desired number will be detailed to explain how such filtering 
defines areas of different chromatographic congestion.  This will be followed by a 
description on how three levels were established for peptide abundance, and how 
peptides were selected to represent each level.  Next, preliminary MRM will be 
presented and justify the removal weak peptides from final MRM consideration.  The 
results of these MRMs will be the subject of the last sections of this chapter, which will 
comment on the viability of MRM in complex samples, the influence of predicted factors, 
and the identification of any unpredicted factors shown to have influence.   
MS/MS analysis of peptides often employs complicated fractionation and secondary 
separation techniques to minimize congestion in chromatographic flows to make low 
abundance peptides more detectable.  This is true even for simple samples such as 
blood or urine.  But with these simple samples, MRM is a regularly selected approach to 
bypass additional separations as its targeted nature excels at ignoring congested areas 
of the chromatogram to detect peptides of low abundance.  Since complicated samples 
present a substantial increase in congestion, and thus further bury low abundance 
peptides, it was decided that these two factors, chromatographic congestion and 
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peptide abundance warranted characterization during the evaluation of MRM 
reproducibility in complex samples.  
Only 12 to 36 peptides would be utilized for MRM evaluation, as this is a comparable 
amount to what is targeted for MRM exploration of a metabolic process, and the 
resultant MRM design would be tested on how reproducibly it measured this handful of 
peptides from among more than 80,000 others in a 60 minute 1D-LC-MS/MS. These 
targets would be selected from a pool of peptides identified by a series of global MS/MS 
measurements.  The peptides selected from this pool would have to possess the traits 
necessary to characterize the effects of chromatographic congestion and peptide 
abundance on MRM performance.  The peptides would also undergo preliminary MRM 
to determine which, if any, of their transitions were suitable for testing reproducibility. 
 
3.2 Characterizing Viable Transitions from Selected Peptides 
Four technical replicates, of a global measurement on the LTQ, yielded 3,827 non-
redundant peptide identifications.  To be considered candidates for the MRM evaluation, 
identified peptides had to be reliably detected and time-specific.  Table 3.1 contains a 
partial list of these 3,827 peptides and their associated metrics.  Five peptides on this 
table, along with their scan times and replicate I.D. counts, are highlighted to exemplify 
how a peptide was, or wasn’t, deemed reliable and specific.   
Peptides were considered reliable if they appeared in all four replicates, as shown 
on the right of Table 3.1 in green.  This criterion is adjustable and could be relaxed to 
provide more candidates if needed; for example, investigating a specific biological 
process may require more options than what stricter criteria allow.  However, selecting 
peptides with lower reliability, such as those shown in yellow, risks diminishing MRM 
reproducibility.   
A peptide’s time-specificity was defined as the peptide having appeared in only one 
5 min window per replicate, and the same five minute window across each replicate; 
these five minute windows are referred to henceforth as bins.  Examples of peptides 
that were specific to one bin are shown on the left of Table 3.1 in yellow, while peptides 
identified in more than one bin are in orange.  It was considered essential that   
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Table 3.1 Excerpt of peptide sequences with first and last scan times, and 
replicate count.  Qualities in green are favorable, qualities in yellow are 
unfavorable.  Peptides in blue qualify as candidates; peptides in red do not 
qualify 
Sequence scan timeearliest (min) scan timelatest (min) Replicate Count
SKEHTTEHLR 0.00965 0.00965 1
SFSHQAGASSK 0.08764 0.08764 1
AQASTHGIGK 0.17481 4.74361 4
KQLDHGQK 0.42847 0.42847 1
TGRNPQTGK 0.51986 0.51986 1
TQDATHGNSLSHR 0.53575 3.65567 2
KLKDEAAK 0.7896 0.7896 1
APAAAAPAAK 1.4402 8.07177 4
SHALNATKR 1.46481 1.46481 1
VYVNKDDTTK 2.51166 6.18079 2
KVHPNDDVNK 1.55398 1.55398 1
MEQELHHR 1.71655 3.65567 2
APHVSEK 1.73009 1.73009 1
DAGGTAEAVR 6.52622 8.95852 4  
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candidates be specific to a bin so that the chromatogram could be reliably divided into 
segments of equal time but differing congestion. 
Peptides such as those in blue were both reliable and specific, and were thus 
candidates for MRM analysis.  Peptides such as those in red lacked reliability, time-
specificity, or both, and thus were not MRM candidates.  415 of the 3,827 identified 
peptides were selected as candidates for MRM analysis. 
The congestion of each bin was determined by how many of the 415 candidate 
peptides were unique to it; Figure 3.1 and Figure 3.2 provide a visualization of how each 
one differed in congestion. These figures show that the most congested bin is at 25 to 
30 minutes, and that the majority of the peptides were identified between 10 and 45 
minutes.  This is because most peptides elute when the mobile phase is between 5% 
and 40% ACN[27], and the gradient employed for this project increased from 5% to 60% 
over 55 min.  With chromatographic congestion adequately defined, its effect on MRM 
quality would be characterized by examining how a peptide from one bin performed 
relative to peptides from other bins.  Performance would be measured in terms of a 
peptide generating viable transitions that produced large sharp peaks with consistent 
areas and retention times. 
In order to evaluate how peptide abundance impacts MRM quality, different levels of 
abundance were established, as displayed in Figure 3.1 and Figure 3.2, but it is 
important to note that because abundances were often based on different MS1 scans, 
comparing two ranks is not a comparison of absolute abundances, but of relative 
abundances.  That is to say, if one peptide were scanned among less abundant 
peptides, while another was scanned among more abundant peptides, the former will 
have a higher rank for its bin, even if the latter is more absolutely abundant. 
Peptides with an average percentile rank of 75% to 100% were considered high 
abundance level, peptides with 50% to 75% were medium level, and peptides with 25% 
to 50% were low level; Figure 3.2 gives the abundance breakdown by bin.  The effect of 
peptide abundance on MRM quality would be characterized by comparing how high, 
medium, and low abundance peptides performed relative to each other.  Depending on 
each bin’s availability, 3 peptides would be selected; the highest of the high abundant,  
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Figure 3.1 Scatter-plot of peptide scan time versus abundance.  Error bars are provided for abundance.
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Figure 3.2 Bar chart of total peptide counts per bin with breakdown by abundance
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the median of the medium abundant, and the lowest of the low abundant.  The limited 
availability of peptides from each abundance level within some bins led to a total of 31 
selected peptides.  Table 3.2 lists these 31 peptides, with their respective percentile 
ranks, and grouped into their respective bins.  It can be seen in the table that 4 bins did 
not have all three possibilities.  As there were only 13 of the 415 peptides with a rank 
below 25%, and considering that these were only present in 3 of the 12 bins, it was 
decided that none of them would be used to evaluate the effect of peptide abundance. 
 
3.3 Evaluation of 31 Selected Peptides by MRM 
The 31 representative peptides were subjected to preliminary MRM scans on the 
QQQ to determine which, if any of their transitions were suitable for a reproducibility 
study.  Skyline software was used to predict the possible transitions for each of the 31 
peptides, and to generate a target list for use in the preliminary MRM’s.  Due to the 
complexity in examining all possible transitions in a single MRM measurement, multiple 
MRM’s were done to scan for the 720 possible transitions.  The results were then 
analyzed in Skyline to determine which transitions were suitable for MRM evaluation, 
and which peptides had a sufficient number of transitions.  Suitability was based on 
consistency, signal strength, evidence of peak origin, and lack of ambiguity.  Figure 3.3 
shows 6 results of the preliminary MRM measurements.  Each is a measurement of 
transitions predicted for a target peptide, and illustrates how the best transitions were 
selected for the final comprehensive MRM’s. 
Transitions demonstrated consistency and signal strength through regular retention 
times and a peak intensity of at least 104, with minimal noise.  If a predicted transition 
only produced random, low intensity peaks, then there would be too much difficulty in 
distinguishing if the signal came from a fragmenting target peptide or just random noise.  
Figure 3.3a and Figure 3.3b each show a spectra generated by the same three 
transitions.  The peaks displayed are of high intensity and regular occurrence, which 
evidences fragmentation of the target peptide; hence these three transitions provide 
useful information on their peptide.  Figure 3.3c and Figure 3.3d also each show a 
spectra generated by another same three transitions, but the peaks displayed are   
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Table 3.2 The 31 selected peptides showing abundance and time bin.  Shadowing 
is to assist in time bin differentiation 
Sequence Abundance Time Bin
N/A N/A
AQASTHGIGK 68.43%
N/A N/A
TPALAAK 93.56%
NGGVAGNTTVNQK 66.82%
LVEGSAQVK 35.23%
TATEYGVVR 93.80%
KVVVEYPK 65.19%
VMQAQGSQLTNK 28.79%
STC[57]TGVEMFRK 78.87%
VDDGGTLDVR 60.72%
LGSHNDMTFGEGTSSR 25.20%
LGQMGELVR 86.53%
TVSENEVPLYK 62.27%
EFNVEANVGKPQVAYR 25.32%
IEIPGC[57]SLC[57]MGNQAR 91.99%
GPASVTNEQIEQVVR 62.37%
FDGNAC[57]VLLNNNSEQPIGTR 28.36%
LAATIAQLPDQIGAK 88.78%
GIVDSNLGLSPATEGQVIR 61.73%
VRELTVQATTGTNSESDLSSIQDEIK 31.04%
VALYGIDYLMK 92.50%
VIDLMC[57]PFAK 62.64%
AVIFAGELLK 37.94%
ANQVPQQVLSLLQG 96.89%
VPDIGADEVEITEILVK 61.45%
DIQLATPPQVGAPATEYAALAELK 45.87%
VGAGPFPTELFDETGEFLC[57]K 76.35%
GITLPETELR 60.57%
N/A N/A
ALLNSMVIGVTEGFTK 84.54%
QSIAVSALSLANQSQQGVLQLLR 66.18%
N/A N/A
VLLPVPFALINDPFGK 88.72%
LMEQITTSDELIDFLTLPGYR 65.03%
N/A N/A
55-60 min
0-5 min
5-10 min
10-15 min
15-20 min
20-25 min
25-30 min
30-35 min
35-40 min
40-45 min
45-50 min
50-55 min
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Figure 3.3 Excerpts from Preliminary MRM Results.  Different line colors indicate 
different transitions.  a & b) Show two replicate measurements of the same 
transitions for the peptide sequence AQASTHGIGK, which have high intensity 
and minimal noise, and the insets show the transitions coincide, which makes 
these ideal for final MRM.  c & d)  Show two replicates of the same transitions for 
QSIAVSALSLANQSQQQGVLQLLR with low intensities and considerable noise, 
making the unsuitable for final MRM.  e) Shows that some transitions for 
GITLPETELR also belong to an interference peptide of similar m/z, but there is 
sufficient evidence to determine the leftmost peaks are from the target peptide, 
while the others are from noise.  f) Shows transitions for TPALAAK that also 
belong to an interference peptide, but there is insufficient evidence to determine 
target from noise. 
  
 38 
 
 
 39 
 
randomly occurring and low intensity.  It is impossible to determine which, if any, of 
these peaks are from the target peptide fragmentation, which makes these transitions 
useless.   
Suitable transitions also needed evidence that their peaks originated from the target 
peptide, and not an interference peptide.  This evidence of origination is provided by a 
transition peak being part of a large set of coinciding transition peaks.  Figure 3.3e 
shows two sets of coinciding peaks.  Both sets appeared because the transitions of 
each are predicted for the target peptide.  But only one set came from the target; the 
other set comprises shared transitions and, came from an interference peptide.  Since 
Skyline predictions were tailored to target peptides, there should be more unique 
transitions than shared, and so the target set should have more peaks.  Thus, when 
determining which peak set in Figure 3.3e originated from the target peptide, there is 
more evidence for set on the left than the set on the right. 
Finally, suitable transitions were required to be free of ambiguity, which was 
demonstrated by generating only one coinciding set of high intensity peaks at a regular 
retention time.  Again, Figure 3.3a and Figure 3.3b show three predicted transitions, 
whose high intensity peaks only coincide once, and so could only come from one 
peptide, the target peptide.  In Figure 3.3f there are three predicted transitions 
producing high intensity peaks that coincide twice, and thus match to two different 
peptides.  The target peptide could be represented by either set, at least one set is from 
an interference peptide, and it is possible that both sets are from interference peptides, 
thus these transitions must be thrown out altogether. 
Some transitions met many of the above criteria, produced strong spectra, and 
appeared to be reliable candidates by initial inspections, but careful scrutiny yielded 
subtle, yet fatal flaws.  The insets in Figure 3.4a show two multi-transition sets, either of 
which could be from the desired peptide or an interference peptide.  The predicted 
retention time favors the latter set, suggesting it is the desired peptide.  However, Figure 
3.4b shows only one transition set, yet the predicted retention time fails to match.  This 
set is reliably believed to be from the target peptide, which would indicate that these 
complicated 1D-LC separations interfere with the reliability of current retention time   
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Figure 3.4 Spectral anomalies resulting in MRM ambiguity.  As before, different 
colored lines indicate different transitions.  a &b) Show inconsistency in 
predicted retention time.  a) Transitions for VALYGIDYLMK also match to 
interference with equivalent evidence, but retention prediction favors the 
rightmost peak.  b) However, transitions for AQASTHGIGK only match the target 
peptide while retention prediction fails to match.  c & d) Show two replicates of 
the same transitions for TPALAAK.  These display further ambiguity as peptide 
evidence and retention times switch between replicates.  
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predictions.  Thus, the ambiguity in Figure 3.4a remains unresolved, and such peptides 
must be discarded.  Figures 3.4c and 3.4d show transition sets that are too close in 
time, and even switch order.  This makes it impossible to pick which transitions 
represent the selected peptide, even if predicted times were reliable.  Further 
complication comes from the sets sharing at least four of their top transitions, thus 
peptides like the one in Figures 3.4c and 3.4d must be discarded. 
These target peptides could be salvaged as viable candidates with newer and more 
discriminating methods for identifying the representative transitions.  Calibrating the 
predicted retention time calculator to better reflect unfractionated samples could help 
the problem in Figure 3.4a, while peptides like the one in Figures 3.4c and 3.4d would 
benefit from reliable transition score predictions that accurately show the rank of the 
fragments for the target peptide. 
Of the 31 selected peptides, 10 lacked suitable transitions and had to be discarded; 
4 of these suffered from ambiguity created by interference peptides, and 6 produced 
poor signal to noise ratios.  Table 3.3 shows the ten discarded peptides and highlights a 
few important observations.  First, peptide abundance appears to have no effect in 
determining which peptides are discarded.  Also, chromatographic location shows no 
apparent trend with a peptide having good transitions, but it does show a trend of early 
eluting peptides suffering more from ambiguity, while later eluting peptides suffered 
more from poor signal to noise. 
The remaining 21 peptides were trimmed to 3 or 4 of their best transitions, and a list 
was created to generate MRM results to evaluate reproducibility in a complex sample.  
Figure 3.5 is an example of the MRM results analysis from Skyline.  The best spectrum 
(Figure 3.5a) came from a medium abundance peptide and show a peak with very high 
intensity and no noise, but the worst spectrum (Figure 3.5b) is of greater interest   
because it was obtained from a low abundance peptide and demonstrates how bad a 
spectrum can look and still be useful.  In spite of the contrast between Figures 3.5a and 
3.5b, the latter’s set is still of sufficient intensity and the only one with coinciding peaks 
(Figure 3.5b inset).  This means that although Figure 3.5a is cleaner and 100 times 
more intense than Figure 3.5b, both spectra yield valuable qualitative and quantitative    
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Table 3.3 The 10 discarded peptides showing abundance, time bin, and reason for 
discarding.  Peptides in white were too ambiguous, while peptides in gray had too 
much noise. 
Sequence Abundance Time Bin Reason
TPALAAK 93.56% Ambiguous
NGGVAGNTTVNQK 66.82% Ambiguous
LGQMGELVR 86.53% 20-25 min Ambiguous
VRELTVQATTGTNSESDLSSIQDEIK 31.04% 30-35 min Low Signal:Noise
VALYGIDYLMK 92.50% 35-40 min Ambiguous
DIQLATPPQVGAPATEYAALAELK 45.87% 40-45 min Low Signal:Noise
ALLNSMVIGVTEGFTK 84.54% Low Signal:Noise
QSIAVSALSLANQSQQGVLQLLR 66.18% Low Signal:Noise
VLLPVPFALINDPFGK 88.72% Low Signal:Noise
LMEQITTSDELIDFLTLPGYR 65.03% Low Signal:Noise
5-10 min
50-55 min
55-60 min
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Figure 3.5 Excerpts of final MRM results.  As before different colored lines 
indicate different transitions.  a-c) Represent the strongest of the final MRM 
spectra and show three replicates of the same transitions for TVSENEVPLYK 
having high intensity, coinciding peaks, and consistent retention times.  d-f) 
Represent the weakest of the final MRM spectra and show three replicates of the 
same transitions for VMQAQGSQLTNK, but insets show them as still having 
adequate intensity, the only coinciding peaks in their respective spectra, and 
consistent retention time. 
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information, and thus both are viable spectra.  All 21 peptides produced viable spectra 
with their selected transitions, regardless of their peptide abundance or 
chromatographic congestion.  This evidence supports conclusion that even in a 
significantly complex sample, low abundance and high congestion do not prohibit 
reliable MRM measurement in 60 minutes.  
However, this conclusion and the results on which it is based, require that the 
congestions and abundances, as established by global experiments, be similarly 
maintained in targeted experiments.  Although both global and targeted measurements 
used the same LC flow rate, chromatographic issues could stem from the LTQ having 
used a split-flow microflow pump while the QQQ employed a split-less nanoflow pump.  
Similarly, the uniform use of quadrupoles and CID fragmentation could not ensure 
abundance continuity since the LTQ and QQQ differ in mass analyzer configuration, 
collision gas, and other intrinsic properties.  Yet this inconsistency is less of a dilemma, 
and more of a showcase for MRM software, as Skyline’s comprehensive data report 
provides evidence for congestion and abundance being preserved across MS/MS 
platforms. 
A portion of data from Skyline’s report was used to generate Table 3.4, which 
demonstrates the sustainment of congestion across MS platforms.  This table shows 
that although only 6 peptides eluted in their original bins, the order of elution was 
maintained for 18 of the 21 peptides.  It also shows that peptides originating from the 
same bin remained close to or fewer than five minutes apart during MRM, with the 
exception of only the last bin.  Finally, this table displays that all retention time standard 
deviations remained well below one minute across all three replicates.  
As support for the preservation of peptide abundance, another selection of Skyline’s 
report is employed by Table 3.5.  Acknowledging that bin location was linked to both 
determining abundance and selecting peptides by it, this table groups peptides 
accordingly and then lists from lowest abundance to highest.  In each bin, peptide order 
by LTQ abundance is reflected in QQQ peak area, again with the exception of the last 
bin.  Table 3.5 also provides direct support for the above conclusion that MRM quality in 
a complex sample is not measurably influenced by abundance or congestion.  
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Table 3.4 The remaining 21 peptides comparing global MS/MS time to MRM time, and predicted order to detected 
order.  Blue values are more favorable, green values are favorable, yellow values are unfavorable 
PeptideSequence Global Bin μ σ Range Pedicted Detected
AQASTHGIGK 0-5 15.24 0.20 N/A 1st 9th
LVEGSAQVK 5-10 8.42 0.23 N/A 2nd 7th
VMQAQGSQLTNK 3.99 0.55
KVVVEYPK 5.05 0.69
TATEYGVVR 5.81 0.51
VDDGGTLDVR 6.79 0.31
LGSHNDMTFGEGTSSR 7.97 0.23
STCTGVEMFRK 8.19 0.26
TVSENEVPLYK 15.06 0.23 8th
EFNVEANVGKPQVAYR 20.53 0.51 10th
GPASVTNEQIEQVVR 23.07 0.47 11th
IEIPGCSLCMGNQAR 28.79 0.61
FDGNACVLLNNNSEQPIGTR 29.49 0.64
LAATIAQLPDQIGAK 32.22 0.65 15th
GIVDSNLGLSPATEGQVIR 35.63 0.61 16th
AVIFAGELLK 39.27 0.48 17th
VIDLMCPFAK 43.37 0.66 18th
ANQVPQQVLSLLQG 52.56 0.60
VPDIGADEVEITEILVK 54.52 0.34
GITLPETELR 26.54 0.54 12th
VGAGPFPTELFDETGEFLCK 55.92 0.15 21st
MRM Retention Time (min) Order
10-15 1.8 3rd, 4th, 5th 1st, 2nd, 3rd
15-20 1.4 6th, 7th, 8th 4th, 5th, 6th
20-25 5.5 9th, 10th
25-30 6.4 11th, 12th, 13th
13th, 14th
30-35 3.4 14th, 15th
19th, 20th
45-50 29.4 20th, 21st
35-40 4.1 16th, 17th
40-45 2.0 18th, 19th
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Table 3.5 The 21 remaining peptides showing factors of possible influence and 
associated MRM performance.  Blue values are more favorable, green values are 
favorable, yellow values are neutrally acceptable, orange values are unfavorable, 
red values are more unfavorable 
PeptideSequence Bin Abundance Length μ Cv
AQASTHGIGK 0-5 68.43% 10 4.9E+06 0.07
LVEGSAQVK 5-10 35.23% 9 8.3E+05 0.73
VMQAQGSQLTNK 28.79% 12 2.0E+05 0.73
KVVVEYPK 65.19% 8 9.8E+05 0.09
TATEYGVVR 93.80% 9 4.6E+06 0.87
LGSHNDMTFGEGTSSR 25.20% 16 9.2E+05 0.60
VDDGGTLDVR 60.72% 10 5.4E+06 0.27
STCTGVEMFRK 78.87% 11 6.9E+06 0.43
EFNVEANVGKPQVAYR 25.32% 16 2.7E+06 0.55
TVSENEVPLYK 62.27% 11 4.6E+07 0.26
FDGNACVLLNNNSEQPIGTR 28.36% 20 1.5E+06 0.22
GPASVTNEQIEQVVR 62.37% 15 1.0E+07 0.34
IEIPGCSLCMGNQAR 91.99% 15 1.1E+07 0.17
GIVDSNLGLSPATEGQVIR 61.73% 19 2.7E+06 0.02
LAATIAQLPDQIGAK 88.78% 15 1.3E+07 0.07
AVIFAGELLK 37.94% 10 1.5E+06 0.33
VIDLMCPFAK 62.64% 10 8.2E+06 0.19
VPDIGADEVEITEILVK 61.45% 17 1.2E+06 0.24
ANQVPQQVLSLLQG 96.89% 14 1.2E+07 0.16
GITLPETELR 60.57% 10 5.4E+06 0.29
VGAGPFPTELFDETGEFLCK 76.35% 20 6.2E+05 0.10
25-30
30-35
35-40
40-45
45-50
Global MRM Peak Area
10-15
15-20
20-25
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Comparing global abundances to MRM peak areas yields no clear trend, and the 
tightest cluster of large peak areas is generated by the most congested part of the 
chromatogram.     
Aside from experimentally distancing complex sample MRM from the influence of the 
predicted factors, this project revealed one influential factor that was not predicted 
during its inception.  Referring to Table 3.6 as an illustration, it was noticed that while 
peptides of 10 amino acids or longer produced strong results with random exceptions, 
peptides that were less than 10 amino acids consistently displayed less reproducibility if 
any at all.  Also referring back to Table 3.5, it would appear that lengths above 20 amino 
acids are questionable targets.  This information will prove to be relevant in chapter 4.  
 
3.4 Summary 
In this chapter a workflow was developed to select robust peptides for evaluating the 
reproducibility of an MRM in a complex sample, containing more than 80,000 peptides, 
with a 60 min 1D-LC-MS/MS.  A discussion of MRM’s abeyance of peptide congestion 
and abundance in small samples, as well as MRM’s typical target size, explained why 
the workflow was also guided to pick approximately 2 dozen peptides for the evaluation 
of each factor’s influence on MRM quality in a complex sample.  Following this 
discussion, the mechanics of the workflow were laid out to validate the characterization 
of each factor’s influence.   This discourse began by detailing how a pool of 3827 
peptides was generated by global MS/MS, and then filtered down to 415 candidates in 
order to define areas of differing chromatographic congestion and characterize 
congestion effects on MRM reproducibility.  The next section was dedicated to 
explaining how the selection 31 peptides provided a range of abundances on which to 
profile the influence of abundance on MRM quality.  Preliminary MRMs of the 31 
peptides were then presented and reviewed to demonstrate how the selected peptides 
were themselves evaluated for suitability in testing both MRM quality and factor 
influence; further explanation was offered as to why 10 peptides were rejected, leaving 
21 for final MRM evaluations.  After depicting the workflow, the final MRM results were 
explored to reveal that all 21 peptides generated  
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Table 3.6 MRM performances of peptides less than 10 amino acids long compared 
to peptides 10 amino acids long.  Blue values are more favorable, green values 
are favorable, yellow values are neutrally acceptable, orange values are 
unfavorable, red values are more unfavorable
PeptideSequence Bin Abundance Length μ Cv
TPALAAK 5-10 93.56% 7 Discard -
KVVVEYPK 10-15 65.19% 8 9.8E+05 0.09
LVEGSAQVK 5-10 35.23% 9 8.3E+05 0.73
TATEYGVVR 10-15 93.80% 9 4.6E+06 0.87
LGQMGELVR 20-25 86.53% 9 Discard -
AQASTHGIGK 00-05 68.43% 10 4.9E+06 0.07
VDDGGTLDVR 15-20 60.72% 10 5.4E+06 0.27
AVIFAGELLK 35-40 37.94% 10 1.5E+06 0.33
VIDLMCPFAK 35-40 62.64% 10 8.2E+06 0.19
GITLPETELR 45-50 60.57% 10 5.4E+06 0.29
Global MRM Peak Area
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reproducible spectra, which supported the verdict that MRM in a complex sample is 
robust and minimally affected by congestion and abundance.  Finally, excerpts from the 
MRM data report were inspected to confirm the preservation of each factor, bolster the 
final verdict, and also identify peptide length as unpredicted factor with a noticeable 
influence on MRM quality. 
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Chapter 4:  Designing and Demonstrating Possible Experimental MRM-MS 
Approaches for Characterizing Specific Metabolic Pathways of a Controlled 
Bacterial Mixture 
 
4.1 Experimental Design for MRM of a Metabolic Pathway 
This chapter contains the second project of this thesis, which was developed to 
profile a metabolic pathway in three organisms using MRM designed for complex 
samples.  It will begin with a quick discussion on the merits of selecting the TCA cycle 
for this study, the origin for the comparison of the ab initio method to the empirical 
method, and the application of conclusions from the previous chapter.  Following this 
discussion, will be descriptions on how MRM is employed to characterize a metabolic 
pathway, precautions for designing such an MRM, and common criteria for both design 
methods.  Then, fundamental differences between the ab initio and empirical will be laid 
out before beginning three comprehensive comparisons.  The first will differentiate how 
each method generates possibilities for building MRM transition lists, and it will contrast 
the numbers generated by each.  The second comparison will explain the uneven 
protein selection as well as focus on how ab initio and empirical differed in ranking 
precursors and fragments for peptide transition selection.  The last comparison will 
assess the MRM performance of each method, and provide a conclusion for the ability 
of MRM to profile a pathway in a complex sample.  This section will also include a 
discussion of how the total numbers to tie back to availability, and how the results for 
shared proteins point to improvements for the ab initio method. 
 
4.2 Selection of a Biological Pathway 
The TCA cycle was selected for this study based partially on its large number of 
enzyme driven reactions and its universal availability, but it was chosen primarily for its 
vital role in cell life.  As seen in the lower part of Figure 4.1, it is a 10 to 12 step process, 
and three organisms in the 4iso sample have well documented TCA cycles, E. coli, R. 
pal, and I .hos; as N. equi relies on the TCA cycle of I. hos, it contains no cycle of its 
own[16].  As for the criticality of this metabolic pathway to sustaining cellular life, the  
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Figure 4.1 KEGG Cycle for TCA.  The nine steps are highlighted to show the 
enzyme commission numbers that were represented in all three organisms, and 
to provide an understanding for the encompassing nature of the characterization 
of this cycle[28] 
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TCA cycle possesses a multifaceted role which is further increased by an ability to drive 
its reactions in reverse order.  The reverse TCA cycle is utilized by some bacteria, such 
as I. hos, for carbon fixation and biosynthesis of amino acid precursors [16, 29], while 
the forward process is central to the catabolism of carbohydrates, fats, and proteins for 
all aerobic organisms.  In the latter instance, the TCA cycle oxidizes the acetyl CoA 
obtained from these biomolecules and generates adenosine triphosphate (ATP), which 
is the primary form of intracellular chemical energy.  For every 1 molecule of acetyl 
CoA, TCA can generate 1 molecule of ATP directly and another 10 ATP molecules 
indirectly through incident coenzymes [30].  This dexterous indispensability of the TCA 
cycle will provide considerable gravity to demonstrating MRM profiling of a metabolic 
pathway. 
However, the conventionally employed empirical approach to MRM design proved 
inadequate, as the preliminary data did not identify enough proteins to characterize the 
cycle for I. hos.  This represents a significant oversight in that I. hos provides an 
uncommon profiling opportunity by possessing a uniquely augmentation to facilitate a 
reversed TCA cycle [16].  The desire to characterize this rare pathway necessitated the 
utilization of an ab initio method to guide the selection of proteins and peptides that 
were missed by empirical means.  Consequently, this project was enriched with the 
secondary objective of comparing these two methods on availability and selection of 
proteins and peptides, and on the performance of their respective MRMs.  These two 
design approaches also link the current project to the previous one by employing 
conclusions from chapter 3; the ab initio method would avoid inclusion of peptides less 
than 10 amino acids long, while the empirical method would use a redefined measure of 
peptide abundance. 
MRM characterizes a metabolic pathway by profiling the enzymatic proteins that 
catalyze its major reactions; targeting a few unique proteins across the beginning, 
middle, and end of a pathway can suffice for characterization.  But as larger pathways 
are considered, more proteins are needed; and naturally, studying more proteins for any 
given pathway provides a more comprehensive understanding of that pathway as a 
whole.  Along with identifying these proteins by their peptides, MRM can profiles the 
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proteins with the spectra generated by the peptide’s transitions.  Under certain 
circumstances, detecting one peptide precursor is sufficient for protein identity and 
profiling, but identities and profiles are not independently reliable unless based on at 
least two peptides with a combined three precursors.  Thus an entire pathway should 
not be characterized solely on proteins with single-peptide profiles, and even doing so 
on dual-peptide profiles could be questionable.  These profiles, and their underlying 
identities, are more reliable when corroborated by an independent counterpart.   
Designing an MRM to characterize a biological pathway involves careful evaluations 
of proteins, peptides, and transitions in order to make good selections, but designing 
that MRM to be done in 60 min, without fractionation, demands accurate knowledge on 
the best selections at each level.  It is important to remember that even the most 
carefully selected peptides may evade detection, and some precursors may not be 
generated in the ion source.  Hence there is no certainty that a selected protein will be 
identified, and proteins with just one peptide precursor are considered unreliable for 
profiling.  But each additional peptide renders its protein more reliable, and each reliable 
protein provides more evidence for a metabolic pathway.  So naturally, designing a 
quality MRM for pathway characterization in a complex sample commands substantial 
availabilities of proteins, peptides, and transitions. 
 
4.3 Two Possible MRM Approaches   
The ab initio and empirical methods shared three criteria for designing MRM.  First, 
TCA proteins were considered for profiling only if their enzyme commission number 
(ECN) was represented in all the three organisms (highlighted in Figure 4.1) [16, 28]. 
This provided continuity on which to directly compare MRM performance in each 
organism, and it naturally defined which proteins would be considered.  One exception 
was made for I. hos to include the four additional proteins that were critical to its 
augmented cycle [16].  The final result included 7 ECNs in all three organisms, plus an 
additional 4 for I. hos, for a total of 46 proteins among them.  The second criterion was 
the exclusion of peptides that contained missed cleavages, as this is an irregular 
occurrence.  Finally, the precursor ions for each peptide had to have m/zs less than 
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1500 to stay within the QQQ’s mass range.  The numbers available to each method, for 
each organism, and at each level, are presented in Table 4.1; here gray numbers signify 
a one to one relationship with the subordinate level.  As stated before, MRM peptide 
attrition rates rendered proteins with only one peptide as too unreliable for profiling.  
And if a given TCA cycle had less than three reliable proteins with each representing a 
different ECN, or if there were no independent proteins in the entire cycle, then an MRM 
would not be designed for that cycle.  
From this point on, fundamental differences between the ab initio approach and the 
empirical approach would lay out separate paths for MRM design.  The ab initio 
approach is relatively new to MRM, and true to its namesake[31], it relies wholly upon 
calculated models to score peptides, precursors, and fragments for transition selections.  
This enables the ab initio method to consider all possibilities, but requires the 
application of logical restrictions to prevent the unnecessary use of time and resource in 
evaluating unlikely candidates.  Also, as there are no preliminary MS/MS experiments, 
this method carries an inherently higher degree of uncertainty.  The empirical method is 
the more traditional approach, and as stated before, takes guidance from preliminary 
measurements.  Although this provides proof that the target protein or peptide is 
available, it is not a guarantee.  Also, this method is limited to what was discovered in 
the preliminary experiments, as any other options would lack the means to be scored.  
The first comparison of MRM design by ab initio and empirical will focus on what 
each method provided for selection, and will begin with empirical method as its selection 
gave rise to this comparison study.  The possibilities for empirical based MRM 
comprised all proteins, peptides, precursors, and fragments that were identified in the 
global MS/MS; this allowed any peptide length, and any precursor or fragment charge 
state.  The global data provided the empirical method with 7 E. coli proteins, and 5 R. 
pal proteins, with all 12 proteins representing a different ECN.  All proteins had at least 
two precursors, and only one protein from each organism had only two precursors.  As 
for I. hos, the data provided only one protein that bore only two peptides, and regardless 
of its lack of independence, this was clearly insufficient to support an empirical MRM of 
I. hos, as was previously stated. 
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Table 4.1 Number of available selections at each level.  Gray numbers signify a 
one to one relationship with the subordinate level. 
Possible
Reaction Protein Peptide Precursor
e.coli 7 7 41 54
r.pal 5 5 21 23
i.hos 1 1 2 2
Total 13 13 64 79
e.coli 7 19 222 222
r.pal 7 13 146 146
i.hos 11 14 141 141
Total 25 46 509 509
Empirical
Ab Initio
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The ab initio based MRM could consider any protein meeting the shared criteria, and 
as this method was not limited to experimentally identified components, it could have 
considered all possibilities of peptides, precursors, and fragments.  However, this could 
mean approximately 60 peptides for each of the 46 proteins; and each peptide would 
average 6 precursors and 9 fragments, which translates into 378 transitions per peptide.  
Aside from snowballing into an avalanche of options that would bury both Skyline and 
its user in endless processing, most of these possibilities are not realistically feasible 
under normal operating conditions; thus the majority of them were weeded out by 
restricting the prediction parameters to only include the properties that were most 
commonly observed.  Specifically, peptide predictions were kept between 10 and 25 
amino acids long, and transition predictions were limited to a +2 precursor charge with a 
+1 fragment charge.  Despite these restrictions, there were still two or more peptides 
available to each of the 46 proteins, and any given TCA cycle could be characterized 
solely by proteins that had 9 or more peptides available.  This meant that every protein 
was available its cycle, and each cycle had the potential for all of its proteins to be 
independently profiled.  Comparing the total numbers in Table 4.1 clearly demonstrates 
that the ab initio method has more options at each level. 
Table 4.2 displays direct comparisons of the availabilities for each method across 
the shared organisms; but more importantly, it provides an understanding of the amount 
that ab initio missed at the peptide and precursor level on account of its restrictions.  
Comparing the shared numbers to the empirical numbers shows that ab initio 
predictions failed to include a total of 7 peptides and 28 precursors that were found in 
the global data.  The lost peptides were filtered out by their lengths, which consequently 
filtered out the 10 precursors found among them.  However, 7 of those 10 would have 
been eventually filtered out by their charge; such was the root of ab initio exclusion for 
the remaining 18 precursors, as these belonged to shared peptides.  Notably, 6 of these 
18 were the only precursors to be empirically available to their respective peptides; this 
explains why the number of shared peptides is 6 more than the number of shared 
precursors.  The importance of identifying the number and cause of these ab initio 
exclusions will be covered in the following discussions of which peptide precursors were  
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Table 4.2 Direct comparison by shared organism of number of available 
selections at each level.  Gray highlight emphasizes discrepancy between 
number of shared peptides and number of shared precursors. 
Possible
Reaction Protein Peptide Precursor
Ab Initio 7 19 222 222
Empirical 7 7 41 54
Shared 7 7 35 29
Ab Initio 7 13 146 146
Empirical 5 5 21 23
Shared 5 5 20 20
Ab Initio 14 32 368 368
Empirical 12 12 62 77
Shared 12 12 55 49
e.coli
r.pal
Both
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selected and detected.  
 
4.4 The MRM Selection Process 
With the possibilities defined, the scoring and selection process could begin.  This 
brings the second comparison of ab initio to empirical, which focuses on how each one 
scored and selected peptide transitions at both the precursor and fragment levels; but 
there is no comparison of protein level selections for three reasons.  First, both methods 
scored proteins with the average score of their top three precursors; ergo a comparison 
of protein selections is merely a comparison of the underlying precursor selections.  
Next, the empirical method provided no alternative proteins for any given ECN; thus a 
protein level comparison would be made not between different methods of selection, but 
between ab initio selection and empirical availability.  Finally, the general lack of 
proteins by empirical method was what led to the inclusion of the ab initio method, and 
as the latter provided the only means for complete characterization in all three 
organisms, it was decided to guide protein selections strictly primarily by their merits for 
characterizing the ab initio method. 
The protein selection numbers are summarized in Table 4.3 and show that ab initio, 
selected 25 proteins; 15 were by default as no alternatives were available, and 10 were 
by top score among alternatives.  To test the effect of selecting a non-default ab initio 
protein with an inferior  probability average, the highest averaging protein was passed 
for the next highest alternative in its ECN; this was E. coli’s p0115[28], and was 
substituted with p0744.  Despite having the inferior average in its own ECN, p0744 had 
a higher average than 19 of the 24 proteins from the other ECNs.  Checking for which 
proteins were shared revealed that all 5 R. pal in empirical had been selected by ab 
initio, and could therefore be used for comparison; this was a hardly coincidence 
though, as four of these proteins were defaults.  Ab initio also selected 5 of the 7 E. coli 
proteins in empirical, with three by default and two by score.  As for empirical’s two E. 
coli proteins that were not selected, one was the above mentioned p0115.  The other 
protein was p0703, which was ranked by ab initio as second to p4043 for their ECN.  
The impact of which proteins were selected and which were skipped will be addressed  
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Table 4.3 Number selected at each level 
Selected
Protein Precursor Fragment
e.coli 5 14 56
r.pal 5 13 52
Total 10 27 108
e.coli 7 21 84
r.pal 7 21 84
i.hos 11 32 128
Total 25 74 296
Empirical
Ab Initio
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in the discussions on what was detected.  
It could be argued that it would have been better to use p0703 to test inferiority in ab 
initio ranks, which would allow p0115 to be selected, and thus all 7 empirical E. coli 
proteins would be used.  However, selecting these peptides presents two drawbacks.  
First, the presence of p0115 is already known and so its profile would only characterize 
selections of peptides and transitions; this in turn would mask the impact of ab initio 
scores on protein selections.  Second, using all 7 E. coli proteins for the comparison 
would further disrupt empirical continuity between E. coli and R. pal. 
With the proteins chosen, the selection process then moved to peptide and transition 
levels, but since ab initio and empirical shared more peptides than precursors, 
comparisons are better explained by currently referring to these levels as precursor and 
fragment selections.  Precursor selection required two to three precursors, representing 
at least two different peptides in empirical’s case, based on availability and score.  This 
selection size maintained protein reliability and independence while minimizing MRM 
duty cycle and the precursor selection numbers are given in Table 4.3.  The empirical 
method scored each precursor by its MII and had multiple precursors available to many 
of its peptides, but it only selected the +2 precursor for all but one of its peptides; for this 
peptide it selected the +2 and +3 precursors.  For two of its proteins, empirical could 
only select two precursors, and it selected none of the 10 precursors that were excluded 
by ab initio restrictions; rendering these exclusions inconsequential.  As for Ab initio 
selection, a precursor’s calculated probability was used for its score, and only one 
precursor was available per peptide, but ab initio selected three precursors for every 
protein to have the maximum number of precursors for each organism.  It should be 
noted that a secondary check of peptide suitability, following this project’s data analysis, 
resulted in the ex post facto removal of one I. hos precursor from the ab initio selection, 
and one R. pal precursor from the empirical selection.  These omissions are reflected in 
all tables, but affected neither ab initio evaluation nor method comparison. 
The final step in the selection process was selecting the top four fragments for each 
precursor, where only fragments with m/zs less than 1500 were considered, and the 
selection size was again chosen to maintain confidence in precursor identity while 
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minimizing MRM duty cycle.  Empirical selection was guided by a visual inspection of 
each precursor’s fragment spectra, and the four fragments with most intense peaks 
were selected.  Naturally, the ab initio method offered no such spectra, but rather it 
guided fragment selection with calculated scores similar to those it used for peptide 
selection.  Again, the total selection numbers are given in Table 4.3, and they show that 
each method selected the maximum number of fragments for their precursors.   
Table 4.4 focuses on shared E. coli and R. pal proteins to offer a direct comparison 
of the ab initio method to the empirical.  Although both methods effectively filled the 
ranks, the ratios in this table make it is easier to see that each did so with mostly distinct 
selections.  The widest gaps exist at the fragment level, yet stem from differences in 
precursor selections, more than fragment selections.  Table 4.5 better illustrates this 
point by drawing from both methods only the precursor numbers from shared proteins, 
and only the fragment numbers from shared precursors.  Looking at both organisms 
together, a total 48 precursors were selected from the 10 shared proteins, but only 9 
precursors were shared among both methods, and they came from only 6 proteins.  As 
a comparison, a total of 46 fragments were selected from those 9 precursors, and 26 of 
those were shared and came from all 9 precursors.  Hence, fragment selection was 
more similar between the two methods than precursor selection. 
 
4.5 Experimental Evaluation of the Two MRM Approaches 
After the selections were made and the transition lists built, the MRM’s designed by 
the ab initio and empirical methods were executed on the QQQ.  The results were 
analyzed with Skyline, where any transitions with weak or irregular signals were 
discarded, and any precursor of less than three viable transitions was also discarded.  
But as mentioned before, single precursor detections were sufficient for identification 
and profiling, provided that an independent protein was present in the same method-
organism scenario.  Table 4.6 lists the targeted proteins by their ECNs and its numbers 
affirm the successful MRM profiling of the TCA cycle in a complex sample with all five 
scenarios providing no less than 4 profiled proteins, and at least one of which was 
independent.  As neither method consistently produced better MRM peak intensities,  
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Table 4.4 Direct comparison by shared protein of number selected at each level, 
also showing number shared for each organism over total for each organism 
Selected
Protein Precursor Fragment
Ab Initio 5 15 60
Empirical 5 14 56
Sha/Tot 5/5 4/25 10/106
Ab Initio 5 15 60
Empirical 5 13 52
Sha/Tot 5/5 5/23 16/96
Ab Initio 10 30 120
Empirical 10 27 108
Sha/Tot 10/10 9/48 26/202
e.coli
r.pal
Both
 
 
 
Table 4.5 Number of shared precursors per protein, and number of shared 
fragments per precursor by organism 
Unit: Precursor Fragment
Base: Protein Precursor
Shared Bases 5 4
Bases with Shared Units 3 4
Units from Shared Bases 25 22
Shared Units 4 10
Shared Bases 5 5
Bases with Shared Units 3 5
Units from Shared Bases 23 24
Shared Units 5 16
Shared Bases 10 9
Bases with Shared Units 6 9
Units from Shared Bases 48 46
Shared Units 9 26
e.coli
r.pal
Both
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Table 4.6 Targeted proteins as identified by their ECNs and showing number of 
precursors detected per protein by organism and method.  N/A is no protein 
available for that ECN; N/E is ab initio selected protein not available to empirical.  
Blue highlighting shows ab initio exclusive protein profiles. 
Enzyme i.hos
Commision Ab initio Empirical Ab initio Empirical Ab initio Em
2.3.3.1 1 3 3 3 2
4.2.1.3 0 N/E 1 2 1
1.1.1.42 3 2 1 2 1 N/E
6.2.1.5 3 3 2 2 2
1.3.99.1 1 N/E 1 N/A 3
4.2.1.2 2 0 1 N/A 0
1.1.1.37 2 2 2 3 3
1.2.1.11 2
6.2.1 1
4.2.1.120 2
4.2.1.55 2
e.coli r.pal
N/A
reactions unique to i.hos
N/A
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the final comparison of the ab initio and empirical was left to the numbers of detected 
proteins, precursors, and fragments as shown in Tables 4.6 and 4.7.  The general 
impression from both tables is that ab initio and empirical performances were 
comparable, with both methods missing one protein each in E. coli, profiling all of their 
target R. pal proteins, and detecting similar numbers of peptides in each organism.  
However, there are some obvious differences and some subtle differences, which 
together point to important conclusions, all of which are discussed below. 
 The numbers in Table 4.7 reveal that ab initio generated 14 more protein profiles 
than empirical, and more than 71% of the total protein profiles.  The highlighting in 
Table 4.6 shows that these additional profiles arose from 10 I. hos proteins, 2 R. pal 
proteins, and 1 E. coli protein that were not discovered by empirical’s global MS/MS.  
The remaining additional profile arose from ab initio selecting two of its exclusive 
peptides to detect a protein that empirical selections missed.  These detection statistics 
point back to the beginning of this project and affirm that ab initio is stronger than 
empirical in regards to availability of proteins and peptides.  The advantage of this 
strength is exemplified by ab initio’s exclusive profiling of the I. hos reverse TCA cycle, 
and is further bolstered by full inclusion of the critical augmentation to this cycle as 
highlighted in Figure 4.2. 
Connecting to another earlier discussion, the E. coli protein that was missed by ab 
initio was p0744, which was selected over p0115 to the test a second rank selection.  
This loss was despite p0744 having a higher average than many of the first ranked 
proteins, and it is made even more unique by being the only non-default protein to be 
missed by either method.  Although it does not conclusively measure the effect of ab 
initio score order on MRM selection, this loss does invite further investigation on the 
topic.   
Another interesting aspect about p0744 is that it was one of only two proteins that 
were not available to empirical while representing ECNs that were; the other was 
p0703, which was ranked first place by ab initio and detected by MRM.  This means 
p0744 was the only targeted protein that was deemed inferior by both methods, and it 
was the only portion of the E. coli TCA cycle to be missed by both methods.  The latter 
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Table 4.7 Number of detected at each level 
Detected
Protein Precursor Fragment
e.coli 4 10 35
r.pal 5 12 44
Total 9 22 79
e.coli 6 12 45
r.pal 7 11 38
i.hos 10 19 76
Total 23 42 159
Empirical
Ab Initio
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Figure 4.2 Excerpt from the updated reconstruction of I. hos metabolism showing 
the augmented reverse TCA cycle for carbon fixation [16].  The numbers that are 
highlighted and underlined in black identify the I. hos proteins for the standard 
TCA cycle that were successfully profiled.  The numbers with blue emphasis 
identify the successfully profiled proteins of the I. hos exclusive augmentation, 
and they demonstrate the full inclusion of this critical addition by MRM pathway 
profiling. 
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statement points to the proteins of both organisms being well profiled across ab initio 
and empirical MRMs together, and is demonstrated in Table 4.8 by comparing the 
numbers of either method to the combined numbers.  It may seem like an obvious 
outcome that the methods would perform better together than separately, but what is 
less pronounced is that a similar performance could be achieved by just one method, 
the ab initio method. 
Considering each method’s numbers for only the shared ECNs, as seen in Table 
4.9, empirical has virtually exhausted its protein options, and is much closer to its limit of 
possible precursors than ab initio, hence there is little room for improvement for the 
former.  Conversely, Table 4.9 demonstrates a wealth of options available to ab initio, 
and aids in method improvement by eliminating protein selection from consideration.  
Recalling from Table 4.5, the methods differ less in fragment selection, which focuses 
improvement measures on increasing peptide precursor selection.  Looking at the 
detected precursor numbers from Table 4.9 reveals that 13 detected precursors were 
selected by the empirical method.  One of these was the aforementioned +3 selection, 
which was excluded from ab initio availability.  But as was also mentioned, each 
remaining precursor was +2 and came from a separate peptide, none of which were 
excluded by ab initio. Thus the 12 peptides that were selected only by empirical were 
still available to ab initio selection, 5 for E. coli and 7 for R. pal.  However, increasing the 
ab initio selection number by just one peptide can bring a significant increase to 
transition list size, as this addition is multiplied across 7 proteins for each organism and 
further multiplied by 4 transitions for each peptide.  Thus a compromise must be met 
between decreasing duty cycle and improving ab initio MRM quality.  Table 4.10 
displays the balance between assimilating empirical selections and overloading 
transition list.  From this table, it can be determined that selecting the top 5 or top 6 
peptides for ab initio would result in an appreciable increase of MRM quality, without 
sacrificing significant duty cycle.  Thus the ab initio method can single-handedly provide 
a more complete TCA profile. 
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Table 4.8 Direct comparison by shared protein of number detected at each level 
Detected
Protein Precursor Fragment
Ab Initio 5 11 42
Empirical 4 10 35
Combined 5 17 67
Ab Initio 5 9 30
Empirical 5 12 44
Combined 5 16 59
Ab Initio 10 20 72
Empirical 9 22 79
Combined 10 33 126
e.coli
r.pal
Both
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Table 4.9 Direct comparison by shared ECNs of numbers available, selected, and detected at each level 
Protein Pecursor Fragment
Possible Selected Detected Possible Selected Detected Selected Detected
Ab Initio 19 5 5 222 15 11 60 42
Empirical 7 5 4 54 14 10 56 35
Shared 7 5 4 29 4 4 10 10
Ab Initio 6 5 5 84 15 9 84 30
Empirical 5 5 5 23 13 12 52 44
Shared 5 5 5 20 5 5 16 15
Ab Initio 25 10 10 306 30 20 120 72
Empirical 12 10 9 77 27 22 108 79
Shared 12 10 9 49 9 9 26 25
e.coli
r.pal
Both
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Table 4.10 Comparison of top n selections showing the number of empirical 
selections assimilated, number of total peptides, and number of total transitions.  
Dark blue values are most desirable, light blue values are more desirable, purple 
values are desirable, light red values are less desirable, and dark red values are 
least desirable. 
Pick Transitions
Emprical Total
top 3 0 21 84
top 4 0 28 112
top 5 2 35 140
top 6 2 42 168
top 9 3 63 252
top 12 5 77 308
top 3 0 21 84
top 4 1 28 112
top 5 3 35 140
top 6 5 42 168
top 9 6 63 252
top 12 7 83 332
Peptides
e.coli
r.pal
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4.6 Summary 
The chapter presented the project of applying MRMs designed for complex samples to 
profile the proteins of TCA cycles for E. coli, R. pal, and I. hos.  As global MS/MS 
provided insufficient empirical data to design MRMs for all three organisms, this project 
introduces an ab initio approach to MRM design, which presented the opportunity to 
compare two competing methods.  This project also took heed of the previous chapter’s 
conclusion on peptide length by applying it to the ab initio method for designing MRM, 
as well as applying the conclusion on peptide abundance by changing its definition for 
the empirical method in this chapter.  An explanation of how MRM profiles a metabolic 
pathway provided context for the common precautions and criteria observed by both ab 
initio and empirical, then a fundamental contrast set the stage for their three 
comprehensive comparisons.  The two methods were first evaluated on what each 
provided in terms of proteins, peptides, and precursors.  As the empirical method’s 
deficiency was the origin for this comparison study, it is no surprise that ab initio had the 
clear advantage in numbers possible at each level; ab initio was also shown to provide 
both a better opportunity for profiling R. pal’s cycle and the only opportunity for I. hos.  
The methods were then assessed for diversity in selections of precursors and 
fragments, and it was demonstrated that they differed more in their ranking of 
precursors than that of fragments.  The final comparison was based on the detection 
results of each methods design, which revealed that MRM profiling of metabolic 
pathways in a complex sample is achievable, and the methods are essentially even in 
selecting viable peptides and transitions for shared proteins.  But, ab initio’s strength in 
availability was proven to be of vital importance as it enabled this method to solely 
profile the TCA cycle of I. hos, and to assimilate some precursor selections that were 
originally unique to empirical, thereby granting ab initio the ability to increase its MRM 
performance. 
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Chapter 5:  Discussion 
The objective of this thesis was to expand the scope of the MRM approach in 
proteomics to include the reproducible analysis of complex samples without the 
assistance of extensive sample preparation. This goal was achieved by executing two 
projects which dually demonstrated an increased understanding of MRM capability, and 
provided depth for this understanding through the success of secondary objectives.  
The first project affirmed MRM reproducibility in a complex sample through the 
demonstration of robust peptide measurements, as evidenced by characterization of the 
influence of predicted and unpredicted factors on MRM quality.  The second project 
illustrated the significance of complex sample MRM design by successfully profiling the 
same metabolic pathway in three microbes from the same complicated sample.  This 
project further displayed the value of MRMs in a complicated mixture through a 
comparison of two evenly matched approaches for MRM design.  
By meeting the objectives of both projects, the work presented in this thesis 
successfully challenged conventional perceptions of MRM limitations.  Compared to the 
traditional MRM samples of blood, plasma, or urine, the 4iso sample presented a vast 
labyrinth with the complete proteomes of E. coli, R. pal, I. hos, and N. equi.  Next, the 
TCA cycle was an ideal pathway choice because of its large number of enzymatic 
reactions and its presence in three of the organisms, but mostly because of its vital role 
in cell life.  Finally, the conventional complex sample strategies of fractionation, 2D-LC, 
and 24 hour run-times were eliminated by the employment of 60 minute 1D-LC-MS/MS. 
In the first thesis project (chapter 3), the generation of reproducible spectra for 
selected peptides from the 4iso sample validated both the MRM of complex samples, 
and the workflow developed to design and evaluate those MRMs.  From global MS/MS 
results for a pool of over three thousand peptides, this workflow sufficiently defined 
regions of differing chromatographic congestion by identifying at least four hundred 
candidates that were consistently detected, and could be grouped into 5 minute bins.  
This workflow also provided an appropriate range in peptide abundance by defining 
three levels therein and identifying one peptide from each level for each bin. The 
explanation for removing weak peptides also provided characterization of peptide length 
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as an unpredicted third influential factor, while congestion and abundance were well 
characterized on the results of the 3 replicate MRMs of the remaining peptides.  These 
characterizations defend the conclusions that congestion and abundance have little if 
any influence on MRM quality in a complex sample, while peptide length is a more likely 
source of loss. 
The second related thesis project (chapter 4) built on the conclusions from the 
chapter 3 work to accomplish the goal of MRM characterization for the  TCA cycles in a 
complex sample, while also providing a venue for the comparison of the ab initio and 
empirical methods for MRM design.  Assessing each method on their availability 
numbers proved ab initio’s advantage in making more proteins accessible for attempted 
profiling, while examining diversity in selection revealed that the methods differed most 
in how each scored precursors.  Although the detection numbers revealed that ab initio 
and empirical were relatively equal in performance on shared proteins, they also clearly 
demonstrated that ab initio’s strength in availability provided more total profiles and 
greater opportunity for improvement. 
Through the demonstration of both MRMs capabilities in complex samples, and ab 
initio’s comparable performance in MRM design, this thesis has authenticated a method 
for metabolic profiling that requires minimal sample preparation and preliminary 
measurements.  The reduced cost in time and money by applying such a method 
carries the potential to greatly increase the wide-spread application of proteomic 
research, as well as the number of complete profiles generated in one study.  The 
predictive software and bioinformatics programs used in this study are freely available, 
and the QQQ platform on which the MRMs were performed is among the most 
attainable instruments.  Even if a researcher cannot afford such an instrument and must 
borrow time on one from another lab, the minimal sample preparation means that most 
of the design can be carried out in an office, allowing for a more efficient use of 
instrument time.  Utilizing ab initio MRM design to profile metabolic pathways in 
complex samples allows researchers greater accessibility for contributing to the ever-
growing proteomics field and its parent field of systems biology. 
Many improvements to method design, separation, and instrumentation are on the 
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horizon, as suggested by this and related studies.  For example, further research into 
the effect of peptide length on MRM quality could produce filters that reduce the 
availability of less meaningful peptides.  Also, as explicitly noted, selecting the top 5 or 
top 6 rated precursors provides a confident expectation of improving MRM quality.  
Improvements to 1D-LC could further reduce sample complication, or alternately allow 
even more complex samples to be attempted.  Specifically, improvements to retention 
time prediction software could recover some the peptides lost to ambiguity, by providing 
more a confident chromatographic identity.  As for instrumentation, the aforementioned 
Q-Exactive is becoming increasingly popular in proteomic MRM, and represents a 
substantial leap forward in acquiring MRM data at superior mass resolution and 
accuracies, thereby reducing ambiguity and interference overlaps.  Performing 
improved ab initio based MRMs of complex samples on such an instrument while 
utilizing the latest updates to 1D-LC will provide the ultra-fast and highly accurate 
metabolic pathway profiles necessary to feed the rapidly increasing demand for 
comprehensive protein level views of cellular genetic expression. 
In total, the MRM-MS approach has seen remarkable advancements and 
implementation in recent proteome research applications.  While the MRM-MS method 
has been widely used in other scientific arenas, the application to systems biology is a 
recent venue.  The work demonstrated in this thesis assists in defining the experimental 
landscape for this methodology by systematically examining how to best define and 
optimize approaches for high-throughput measurements of moderately complex 
microbial systems. 
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